Gregory T. Went, Chief Executive Officer at Adamas Pharmaceuticals Inc (ADMS), sold 9,082 shares at $25.75 ($234K) on 2018-03-21, disclosed to the SEC on 2018-03-22.
Seasonal sale ($234k) by Chief Executive Officer — this insider has traded ADMS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.75 | 4,541 | $117K | 50.0% |
| 2 | $25.75 | 4,541 | $117K | 50.0% |
| Total | $25.75 avg | 9,082 | $234K | 100% |
| Filing → |
| ADMS | SELL | 2017-03-22 | $48K | — | Filing → |
| ADMS | SELL | 2015-05-14 | $49K | — | Filing → |
| ADMS | SELL | 2015-04-27 | $59K | — | Filing → |